KevinSelleryGreggMD
Infectious Disease • Ann Arbor, MITransplant/Immunocompromised States
Clinical Professor, Division of Infectious Diseases
Dr. Gregg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
F4156 University Hospital South
Ann Arbor, MI 48109Phone+1 734-763-7364Fax+1 734-936-2737
Education & Training
University of ChicagoFellowship, Infectious Disease, 2007 - 2011- University of ChicagoResidency, Internal Medicine, 2004 - 2007
Case Western Reserve University School of MedicineClass of 2004
Certifications & Licensure
MI State Medical License 2011 - 2027
IL State Medical License 2004 - 2011- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen Start of enrollment: 2014 Mar 01
- Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) Start of enrollment: 2012 Oct 10
- Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates Start of enrollment: 2024 Mar 05
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation.Keerthi T Gondi, Daniel R Kaul, Kevin S Gregg, Jessica R Golbus, Keith D Aaronson
The Journal of Heart and Lung Transplantation. 2024-03-01 - 3 citationsAn Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving C...Krishna Rao, Qianzi Zhao, Justin Bell, Jay Krishnan, Oryan Henig
Clinical Infectious Diseases. 2024-02-17 - Donor-Derived Disseminated Toxoplasmosis in a Liver Transplant Recipient With Documented Sulfa Allergy.Zoe Raglow, Emily Herriman, Gabriel Abrams, Marc Najjar, Christopher J Sonnenday
Case Reports in Transplantation. 2024-01-01
Journal Articles
- A Randomized, Placebo-Controlled Trial of Fidaxomicin for Prophylaxis of Clostridium Difficile Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transpl...Kevin Gregg, Javier A Adachi, Steven A Pergam, Clinical Infectious Diseases
Press Mentions
Back-to-School Concerns: U-M Experts AvailableAugust 10th, 2021- Ann Arbor Medical and Mental Health Doctors Want Date for in-Person School Learning OptionFebruary 8th, 2021
Professional Memberships
- Member
- Member
- American Society of TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
